These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9228128)

  • 1. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.
    Bluhm GB; Sharp JT; Tilley BC; Alarcon GS; Cooper SM; Pillemer SR; Clegg DO; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Leisen JC; Buckley L; Duncan H; Tuttleman M; Li S; Fowler SE
    J Rheumatol; 1997 Jul; 24(7):1295-302. PubMed ID: 9228128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
    Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Kaplan DA; Clegg DO; Leisen JC; Buckley L; Cooper SM; Duncan H; Pillemer SR; Tuttleman M; Fowler SE
    Ann Intern Med; 1995 Jan; 122(2):81-9. PubMed ID: 7993000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis.
    Pillemer SR; Fowler SE; Tilley BC; Alarcón GS; Heyse SP; Trentham DE; Neuner R; Clegg DO; Leisen JC; Cooper SM; Duncan H; Tuttleman M
    Arthritis Rheum; 1997 Mar; 40(3):419-25. PubMed ID: 9082927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.
    O'Dell JR; Paulsen G; Haire CE; Blakely K; Palmer W; Wees S; Eckhoff PJ; Klassen LW; Churchill M; Doud D; Weaver A; Moore GF
    Arthritis Rheum; 1999 Aug; 42(8):1691-5. PubMed ID: 10446869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.
    Kirwan JR
    N Engl J Med; 1995 Jul; 333(3):142-6. PubMed ID: 7791815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B; Alvaro-Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P
    Arthritis Rheum; 1998 Dec; 41(12):2196-204. PubMed ID: 9870876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.
    Stone M; Fortin PR; Pacheco-Tena C; Inman RD
    J Rheumatol; 2003 Oct; 30(10):2112-22. PubMed ID: 14528503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline.
    Alarcón GS; Bartolucci AA
    J Rheumatol; 2000 Feb; 27(2):530-4. PubMed ID: 10685828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.
    O'Dell JR; Blakely KW; Mallek JA; Eckhoff PJ; Leff RD; Wees SJ; Sems KM; Fernandez AM; Palmer WR; Klassen LW; Paulsen GA; Haire CE; Moore GF
    Arthritis Rheum; 2001 Oct; 44(10):2235-41. PubMed ID: 11665963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification).
    van der Heijde DM; van Leeuwen MA; van Riel PL; van de Putte LB
    J Rheumatol; 1995 Sep; 22(9):1792-6. PubMed ID: 8523365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug.
    Rich E; Moreland LW; Alarcón GS
    J Rheumatol; 1999 Feb; 26(2):259-61. PubMed ID: 9972955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease.
    Kuper IH; van Leeuwen MA; van Riel PL; Sluiter WJ; Houtman NM; Cats HA; van Rijswijk MH
    J Rheumatol; 1999 Feb; 26(2):268-76. PubMed ID: 9972957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
    Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
    Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Haire CE; Palmer W; Drymalski W; Wees S; Blakely K; Churchill M; Eckhoff PJ; Weaver A; Doud D; Erikson N; Dietz F; Olson R; Maloley P; Klassen LW; Moore GF
    Arthritis Rheum; 1997 May; 40(5):842-8. PubMed ID: 9153544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.
    Tuttleman M; Pillemer SR; Tilley BC; Fowler SE; Buckley LM; Alarcón GS; Trentham DE; Neuner R; Clegg DO; Leisen JC; Heyse SP
    J Rheumatol; 1997 Oct; 24(10):1910-5. PubMed ID: 9330931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA.
    Alarcón GS; Tilley BC; Li S; Fowler SE; Pillemer SR
    J Rheumatol; 1999 May; 26(5):1065-7. PubMed ID: 10332969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of progression of erosive damage in previously eroded joints in early rheumatoid arthritis trials: COBRA trial as an example.
    Bruynesteyn K; Van Der Heijde D; Boers M; Verhoeven A; Boonen A; Van Der Linden S;
    Arthritis Rheum; 2002 Oct; 47(5):532-6. PubMed ID: 12382303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
    Mayes MD; O'Donnell D; Rothfield NF; Csuka ME
    Arthritis Rheum; 2004 Feb; 50(2):553-7. PubMed ID: 14872498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.